B Group Inc. Invests $5.43 Million in Bright Minds Biosciences
On May 15, 2026, B Group Inc. disclosed a new investment in Bright Minds Biosciences (DRUG), acquiring 67,500 shares valued at approximately $5.43 million based on Q1 average pricing. The stake represents about 4% of the firm's reportable AUM as of March 31, 2026.
Tickers: $DRUG
Topics: biotech investment activity SEC filings